Undisclosed RD hematological cancers
Strand Therapeutics is developing mRNA therapeutics to treat cancer, heart diseases and rare diseases. mRNA has recently emerged as an effective, multi-functional and potentially curative treatment option for many patients. Strand’s approach to mRNA therapeutics is unique - creating mRNA constructs that contain information for self-replication and genetically programmed logic circuits. This application of synthetic biology to RNA therapeutics enables the creation of programmable, long-acting mRNA drugs such that the location, timing and intensity of expression can all be controlled. Stand has initially focused on treatment options for solid tumor cancers.
Associate Scientist, Nanoparticle Process Developm...
Boston, MA|46 days ago
Scientist/Sr Scientist, Analytical Development
Boston, MA|85 days ago
Principal Scientist, Translational Biology
Boston, MA|100+ days ago